Navigation Links
Omeros to Present at Oppenheimer 24th Annual Healthcare Conference
Date:12/5/2013

SEATTLE, Dec. 5, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the Oppenheimer 24th Annual Healthcare Conference in New York City next week.  The presentation is scheduled for Wednesday, December 11, 2013 at 1:35 p.m. EST.

The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page of the Company's website at www.omeros.com.  

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics targeting inflammation, coagulopathies and disorders of the central nervous system. Derived from its proprietary PharmacoSurgery® platform, the Company's lead drug product, OMS302 for lens replacement surgery, is currently under review for marketing approval by both the US Food and Drug Administration and the European Medicines Agency with commercial launch planned for 2014. Omeros' five other clinical programs are focused on schizophrenia, Huntington's disease and cognitive impairment; addictive and compulsive disorders; complement-related diseases; and preventing problems associated with surgical procedures. Omeros also has a proprietary GPCR platform, which is making available an unprecedented number of new GPCR drug targets and corresponding compounds to the pharmaceutical industry for drug development.


'/>"/>
SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Omeros Reports Phase 3 OMS302 Clinical Data Presented at the Annual American Academy of Ophthalmology Meeting
2. Omeros Announces Positive OMS721 Data in Model of Age-Related Macular Degeneration
3. FDA Grants Orphan Drug Designation to Omeros OMS824 for Huntingtons Disease
4. Omeros Chosen to Present at NewsMakers in the Biotech Industry 2013 Conference
5. Omeros Reports Initiation of Phase 2 Clinical Trial with OMS824
6. Omeros Reports Additional Positive Results from OMS824 Program
7. Omeros Submits OMS302 Marketing Authorization Application to European Medicines Agency
8. Omeros to Present at the Stifel Healthcare Conference 2013
9. Michael A. Jacobsen Joining Omeros as Vice President, Finance and Chief Accounting Officer
10. Omeros Corporation Reports Second Quarter 2013 Financial Results
11. Omeros to Present at the Wedbush 2013 Life Sciences Management Access Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... OTTAWA , Sept. 20, 2014 /CNW/ - The issue: ... voluntarily recalling all lots of its Mylan-Nitro Spray 0.4 mg/metered ... is part of the pump component. A ... delivery of nitroglycerin to the patient. This defect may lead ... fact they are unable to access it. Not receiving nitroglycerin ...
(Date:9/19/2014)... HILL, N.C. , Sept. 19, 2014 /PRNewswire/ ... role in forging relationships with key opinion leaders ... market and competition. Despite the critical nature of ... created many challenges, including altering the landscape for ... According to research, the oversight responsibility ...
(Date:9/19/2014)... , Sept. 19, 2014 Harwood Feffer LLP ... board of directors of PDL BioPharma, Inc. ("PDL" or ... the board has breached its fiduciary duties to shareholders ... September 16, 2014, the Company disclosed: "On September 11, ... accounting firm, Ernst & Young LLP ("EY"), that it ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
(Date:9/21/2014)... 2014 More than a quarter of house ... start in one of two ways. The first type of ... The second type of dryer fire occurs when lint builds ... also catch fire due to malfunctioning electrical systems so if it ... a look!) Here are some ways that you can prevent ...
(Date:9/21/2014)... London, United-Kingdom (PRWEB) September 22, 2014 ... Fergus Sweeney and Dr. Lilliam Rosario as keynote speakers ... Transparency”. Following keynotes from Dr. Ben Goldacre in ... Professor Lord Winston in 2011 , PhUSE again ... professions who are passionate about advancement of clinical information. ...
(Date:9/21/2014)... likely to trigger an allergy to peanuts than raw ... The researchers say that specific chemical changes caused by ... recognised by the body,s immune system, ,priming, the body ... time it sees any peanuts. , The results might ... peanut allergies in the Western world compared to populations ...
(Date:9/21/2014)... 2014 Burnaby Physiotherapists at Absolute PhysioCare ... in order to help them with preventative care. This ... clinic that will help clients understand their problem in ... active participation in the healing process. With higher knowledge ... be able to facilitate the therapy that is initiated ...
(Date:9/21/2014)... Expert witness work is in! That ... its 2014 Expert Witness Fees & Practices Survey. With ... and compensation for qualified and credentialed expert witnesses has ... history. , The nearly 600 experts surveyed reported ... work, an increase of 3.2% from ExpertPages’ 2012 survey. ...
Breaking Medicine News(10 mins):Health News:Restoration Local Offers Tips to Avoid Dryer Fires 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 3Health News:PhUSE announces Final List of Industry Influencers as Keynote Speakers 2Health News:PhUSE announces Final List of Industry Influencers as Keynote Speakers 3Health News:Dry roasting could help trigger peanut allergy 2Health News:Burnaby Physiotherapists Now Provide Educational Information for Preventative Care 2Health News:ExpertPages 2014 Survey Reports Expert Witness Hourly Fees Record All-Time Highs as Demand for Qualified Experts Continues to Grow 2
... WellPoint, Inc. (NYSE: WLP ) announced ... New York Attorney General regarding the manner in which ... terms of the Agreement with the Attorney General, WellPoint ... database, which it uses in determining out-of-network reimbursement for ...
... RI Researchers at Rhode Island Hospital have completed ... control measures during a possible flu pandemic. Their study ... from individuals showing no symptoms (asymptomatic) or from individuals ... The researchers call on the scientific community to ...
... LOUISVILLE, Ky., Feb. 18 Almost Family, Inc. (Nasdaq: ... nursing services, announced today that it will be added to ... on Friday, February 20, 2009.William Yarmuth, President and CEO of ... included in the S&P SmallCap 600 Index, as it adds ...
... Taking Control of Your Diabetes,(TCOYD) announced findings ... firm Yankelovich that found that more than one ... that excess weight has a positive effect on,the ... often contributes,to the development of diabetes, complicates proper ...
... love their meat. Whether it,s rib eyes, pork chops or ... this country that more than 85 billion pounds of meat ... About a quarter of U.S. beef and pork is exported ... now the world,s largest consumer of meat, in Mexico, meat ...
... Spanish . , A team of specialists ... of genetic variants that have greater resistance to a specific ... some child patients affected by osteosarcoma. The team investigated the ... therapeutic treatment in the future. , In concrete, the research ...
Cached Medicine News:Health News:WellPoint Joins New York Attorney General in Creation of New Independent Database for Out-of-Network Reimbursement 2Health News:Study calls for increased research in flu transmission to prepare for pandemic flu outbreak 2Health News:Almost Family to be Added to the S&P SmallCap 600 Index 2Health News:One in Five Augustans With Type 2 Diabetes Mistakenly Believe That Being Obese or Overweight Can Positively Impact Their Disease 2Health News:One in Five Augustans With Type 2 Diabetes Mistakenly Believe That Being Obese or Overweight Can Positively Impact Their Disease 3Health News:American Veterinary Medical Association: Weaving a Web for Food Safety 2Health News:Research increases possibilities of personalizing treatment of infant osteosarcoma 2Health News:Research increases possibilities of personalizing treatment of infant osteosarcoma 3
... to use, the Gel XL Ultra includes all ... The unit is compact, requiring a minimal amount ... a tangled mess of leads and cords on ... and convenience, the power supply can detect when ...
... has a centimeter ruler etched into the gel ... It includes apparatus, connecting cables, three 7x10 cm ... and three 14-well combs. The Chameleon can accomodate ... electrophoresis of a maximum of 120 samples with ...
... (patented) provides unparalleled reproducibility, speed and convenience ... combination with Elchrom Scientific AG ready-to-use gels ... a regular submarine plus a vertical or ... it is possible to get the best ...
... gels offer many advantages for nucleic acid ... for the molecular biologist. Agarose gels are ... These gels allow sample underlaying and prevent ... sample well dehydration. Horizontal systems are more ...
Medicine Products: